This is a pitch from Jason Stutman’s The Cutting Edge newsletter, his higher-end service from Angel Publishing (about $1,500/year), and what caught my eye was the headline promise that Harvard University is “calling for a 29,000% surge for one tiny company you’ve never heard of.” So what is it? Well, it’s appropriate that we’re looking […]
Articles
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Have a look at Adapt Pharma and the product is Narcan Nasal Spray. An antidote to be used e.g. in connection with an opi...
Doc Kss I cannot locate the proof of concept trial data either.I think their partner Adapt Pharma did this.I did find th...
One to take a look at that may be quite a bit undervalued with a 13 million dollar MC and a nasal drug partnered with Ad...